Be part of the Transformation in veterinary medicine

We love the pets around us – our dogs, cats, and horses we share our lives with. Many of us believe these animals are part of the family, providing us unconditional love and companionship throughout our lives. We have an opportunity for cutting edge treatment when disease and chronic conditions cross our path, but what happens when our animal companions encounter these same issues?

Treatment options for our companion animals shouldn’t be limited

So KindredBio is working hard to develop innovative new treatment options for the veterinary industry

  • Please provide an email address and we'll send you updates on our progress

Remember, by submitting your email address, you are agreeing to receive updated information from KindredBio!

Download the Corporate Presentation to learn more about our strategy, team, and programs.

Read the Recent News from KindredBio.

Elanco Announces Agreement to Acquire Kindred Biosciences

June 16, 2021/in Frontpage, Investor, News /by Katja Buhrer

Bolt-on Acquisition Accelerates Elanco’s Expansion in Pet Health Elanco to host conference call for investment community at 8:00 am Eastern Time   Elanco will acquire all outstanding stock of Kindred Biosciences at a price of $9.25 per share, or approximately $440 million, a premium of 52% based on the 30-day average. Transaction brings three potential […]

Read more
/wp-content/uploads/2017/09/KindredBioHeader2017.png 0 0 Katja Buhrer /wp-content/uploads/2017/09/KindredBioHeader2017.png Katja Buhrer2021-06-16 06:57:442021-06-16 07:01:36Elanco Announces Agreement to Acquire Kindred Biosciences

Kindred Biosciences Announces Positive Results from Pivotal Efficacy Study of Parvovirus Monoclonal Antibody for the Prevention of Deaths in Dogs Infected by Parvovirus

June 2, 2021/in Frontpage, Investor, News /by Katja Buhrer

Study demonstrated 100% survival in dogs treated with KIND-030, even in the absence of any supportive care, versus 43% survival in dogs treated with placebo San Francisco, California (June 2, 2021) – Kindred Biosciences, Inc. (NASDAQ: KIN), a biopharmaceutical company focused on saving and improving the lives of pets, today announced positive results from a […]

Read more
/wp-content/uploads/2017/09/KindredBioHeader2017.png 0 0 Katja Buhrer /wp-content/uploads/2017/09/KindredBioHeader2017.png Katja Buhrer2021-06-02 08:45:202021-06-02 08:45:21Kindred Biosciences Announces Positive Results from Pivotal Efficacy Study of Parvovirus Monoclonal Antibody for the Prevention of Deaths in Dogs Infected by Parvovirus

Kindred Biosciences to Present at Stifel 2021 Virtual Jaws & Paws Conference and LD Micro Invitational XI

May 25, 2021/in Frontpage, Investor, News /by Katja Buhrer

SAN FRANCISCO, May 25, 2021 — Kindred Biosciences, Inc. (NASDAQ: KIN), a biopharmaceutical company focused on saving and improving the lives of pets, will present at the Stifel 2021 Virtual Jaws & Paws Conference on June 2 and the LD Micro Invitational XI on June 8.    Dr. Richard Chin, Chief Executive Officer, will be available for one-on-one […]

Read more
/wp-content/uploads/2017/09/KindredBioHeader2017.png 0 0 Katja Buhrer /wp-content/uploads/2017/09/KindredBioHeader2017.png Katja Buhrer2021-05-25 08:57:272021-05-25 08:57:28Kindred Biosciences to Present at Stifel 2021 Virtual Jaws & Paws Conference and LD Micro Invitational XI
View all press releases

Looking for More?

The Management Team

We have a world class leadership team guiding us in our quest to develop the best medicines for our best friends.

See Our Pipeline

KindredBio has an exciting pipeline of high-value products for dogs, cats, and horses in development.

News

  • Elanco Announces Agreement to Acquire Kindred BiosciencesJune 16, 2021 - 6:57 am
  • Kindred Biosciences Announces Positive Results from Pivotal Efficacy Study of Parvovirus Monoclonal Antibody for the Prevention of Deaths in Dogs Infected by ParvovirusJune 2, 2021 - 8:45 am
  • Kindred Biosciences to Present at Stifel 2021 Virtual Jaws & Paws Conference and LD Micro Invitational XIMay 25, 2021 - 8:57 am

Events

  • Event: Kindred Biosciences to Present at the LD Micro Invitational XIMay 25, 2021 - 9:14 am
  • Event: Kindred Biosciences to Present at the Stifel 2021 Virtual Jaws & Paws ConferenceMay 25, 2021 - 9:12 am
  • Event: Kindred Biosciences to Announce Fourth Quarter and Full Year 2020 Financial ResultsMarch 8, 2021 - 8:48 am
Contact Us | Careers | Privacy Policy | Website Terms of Use | Forward Looking Statements
© Copyright 2012-2020 | Kindred Biosciences, Inc. | 1555 Bayshore Hwy. Suite 200 Burlingame, CA 94010
Scroll to top